BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10992882)

  • 21. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [NF-kappa B and prostatic adenocarcinoma].
    Xiang ST; Guo H; Zhou SW
    Zhonghua Nan Ke Xue; 2003 Oct; 9(7):536-8, 542. PubMed ID: 14628608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
    Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine gene expression and activation of NF-kappa B in aniline-induced splenic toxicity.
    Wang J; Kannan S; Li H; Khan MF
    Toxicol Appl Pharmacol; 2005 Feb; 203(1):36-44. PubMed ID: 15694462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.
    Toda M; Martuza RL; Rabkin SD
    Gene Ther; 2001 Feb; 8(4):332-9. PubMed ID: 11313808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines.
    Lun M; Zhang PL; Siegelmann-Danieli N; Blasick TM; Brown RE
    Ann Clin Lab Sci; 2005; 35(1):15-24. PubMed ID: 15830705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines.
    Tacchini L; De Ponti C; Matteucci E; Follis R; Desiderio MA
    Carcinogenesis; 2004 Nov; 25(11):2089-100. PubMed ID: 15240510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference.
    Zhou A; Scoggin S; Gaynor RB; Williams NS
    Oncogene; 2003 Apr; 22(13):2054-64. PubMed ID: 12673210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 and NFkappaB: fresh breath in the cross talk.
    Tergaonkar V
    Cell Res; 2009 Dec; 19(12):1313-5. PubMed ID: 19956183
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gene therapy for colon cancer targeting NF-kappa B].
    Kokura S; Yoshikawa T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():515-8. PubMed ID: 14574947
    [No Abstract]   [Full Text] [Related]  

  • 31. [NF kappa B decoy for clinical applications].
    Suzuki J; Isobe M
    Nihon Rinsho; 2003 Oct; 61(10):1829-35. PubMed ID: 14577311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for asthma: inspired research or unnecessary effort?
    Alton EW; Griesenbach U; Geddes DM
    Gene Ther; 1999 Feb; 6(2):155-6. PubMed ID: 10435098
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of nuclear factor-kappa B in melanoma.
    Amiri KI; Richmond A
    Cancer Metastasis Rev; 2005 Jun; 24(2):301-13. PubMed ID: 15986139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The activation and function of p53 in cellular response to environmental stress].
    Yamamoto K
    Tanpakushitsu Kakusan Koso; 1999 Nov; 44(15 Suppl):2507-10. PubMed ID: 10586708
    [No Abstract]   [Full Text] [Related]  

  • 35. Nuclear factor-kappa B as potential therapeutic target in human colon cancer.
    Plewka D; Plewka A; Miskiewicz A; Morek M; Bogunia E
    J Cancer Res Ther; 2018; 14(3):516-520. PubMed ID: 29893308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF-kappaB and breast cancer.
    Nakshatri H; Goulet RJ
    Curr Probl Cancer; 2002; 26(5):282-309. PubMed ID: 12429950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of allergic diseases by NFkappaB decoy DNA].
    Tamai K
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():660-4. PubMed ID: 20979312
    [No Abstract]   [Full Text] [Related]  

  • 38. [NFkappaB decoy DNA for treatment of atopic dermatitis].
    Tamai K; Kaneda Y; Nakamura H; Aoki M; Morishita R; Hashimoto K; Morita A; Katayama I; Hanada K
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():659-63. PubMed ID: 16416870
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapies that make sense.
    Akhtar S; Ivinson AJ
    Nat Genet; 1993 Jul; 4(3):215-7. PubMed ID: 8358426
    [No Abstract]   [Full Text] [Related]  

  • 40. NF-kappa B, a prototypical cytokine-regulated transcription factor: implications for alcohol-mediated responses.
    Zakhari S
    Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):236A-242A. PubMed ID: 8947272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.